Wolverine Trading’s Arcturus Therapeutics ARCT Stock Holding History

Wolverine Trading’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,900	Closed	-$284K	–	5214
2024 Q3	$284K	Buy	+12,900	New	+$276K	﹤0.01%	3691
2024 Q1	–	Sell	-11,700	Closed	-$369K	–	4457
2023 Q4	$369K	Buy	11,700 +3,300	+39%	+$78.4K	﹤0.01%	3263
2023 Q3	$215K	Buy	+8,400	New	+$259K	﹤0.01%	3680
2022 Q2	–	Sell	-16,700	Closed	-$460K	–	4447
2022 Q1	$460K	Sell	16,700 -5,100	-23%	-$130K	﹤0.01%	3339
2021 Q4	$848K	Buy	+21,800	New	+$888K	﹤0.01%	2814
2021 Q2	–	Sell	-26,900	Closed	-$1.04M	–	5876
2021 Q1	$1.04M	Sell	26,900 -27,400	-50%	-$1.63M	﹤0.01%	2705
2020 Q4	$2.54M	Buy	54,300 +31,300	+136%	+$2.12M	﹤0.01%	1512
2020 Q3	$983K	Buy	23,000 +1,300	+6%	+$64.5K	﹤0.01%	2105
2020 Q2	$1.02M	Buy	+21,700	New	+$748K	﹤0.01%	1979
2020 Q1	–	Sell	-13,000	Closed	-$135K	–	4578
2019 Q4	$135K	Buy	+13,000	New	+$136K	﹤0.01%	4190
2016 Q4	–	Sell	-7,657	Closed	-$135K	–	4408
2016 Q3	$135K	Sell	7,657 -72	-0.9%	-$2.33K	﹤0.01%	4058
2016 Q2	$235K	Buy	+7,729	New	+$244K	﹤0.01%	3087

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Wolverine Trading's ARCT Position: Q3 2025 in Review

Wolverine Trading increased its Arcturus Therapeutics (ARCT) stake by 5.5% in Q3 2025, buying an estimated $12.2K and bringing the position to 14,610 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Wolverine Trading first reported a position in ARCT in Q2 2020 and has held it in 6 quarters since. The position peaked at $943K in Q2 2020. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

Wolverine Trading held 14,610 shares of Arcturus Therapeutics worth $274K as of Q3 2025.
Wolverine Trading bought 760 Arcturus Therapeutics shares in Q3 2025, an estimated $12.2K.
Arcturus Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4514 holding.
Wolverine Trading first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 6 quarters since.
Wolverine Trading's Arcturus Therapeutics position peaked at $943K in Q2 2020.
136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.